Get the Stockscreener App
32.11
7.12%
-2.46
After Hours:
32.11
Conmed Corp stock is traded at $32.11, with a volume of 921.32K.
It is down -7.12% in the last 24 hours and down -9.52% over the past month.
Conmed Corp is a medical technology company that provides devices and equipment for surgical procedures. The company's products are used by surgeons and other healthcare professionals across specialties, including orthopedics, general surgery, gynecology, thoracic surgery, and gastroenterology. Geographically, the company operates in the United States, Europe, the Middle East & Africa, Asia Pacific, and the Americas, excluding the United States. The majority of revenue is generated from the United States.
See More
Previous Close:
$34.57
Open:
$34.05
24h Volume:
921.32K
Relative Volume:
2.05
Market Cap:
$966.81M
Revenue:
$1.37B
Net Income/Loss:
$54.85M
P/E Ratio:
18.11
EPS:
1.7729
Net Cash Flow:
$123.71M
1W Performance:
-11.54%
1M Performance:
-9.52%
6M Performance:
-19.32%
1Y Performance:
-38.53%
1-Day Range:
$31.84
$34.82
1-Week Range:
$31.84
$36.33
52-Week Range:
$31.84
$56.63
Conmed Corp Stock (CNMD) Company Profile
Name
Conmed Corp
Sector
Industry
Phone
727-214-2974
Address
11311 CONCEPT BOULEVARD, LARGO, NY
Compare CNMD vs ABT, SYK, MDT, BSX, EW
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CNMD
Conmed Corp
|
32.11 | 1.03B | 1.37B | 54.85M | 123.71M | 1.7729 |
ABT
Abbott Laboratories
|
88.50 | 154.45B | 45.13B | 6.28B | 7.38B | 3.5895 |
SYK
Stryker Corp
|
301.14 | 118.05B | 25.27B | 3.34B | 4.57B | 8.6334 |
MDT
Medtronic Plc
|
78.14 | 103.20B | 36.36B | 4.84B | 5.43B | 3.7212 |
BSX
Boston Scientific Corp
|
44.95 | 69.50B | 20.62B | 3.56B | 3.48B | 2.3847 |
EW
Edwards Lifesciences Corp
|
86.68 | 49.68B | 6.30B | 1.07B | 1.09B | 1.8406 |
Conmed Corp Stock (CNMD) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Mar-17-26 | Downgrade | Piper Sandler | Overweight → Neutral |
| Jun-12-25 | Downgrade | Needham | Buy → Hold |
| Apr-28-25 | Downgrade | Stifel | Buy → Hold |
| Feb-06-25 | Downgrade | JP Morgan | Overweight → Neutral |
| Feb-01-24 | Reiterated | Needham | Buy |
| May-22-23 | Initiated | CL King | Buy |
| Mar-27-23 | Upgrade | KeyBanc Capital Markets | Sector Weight → Overweight |
| Mar-21-23 | Initiated | Wells Fargo | Equal Weight |
| Oct-12-22 | Initiated | Jefferies | Hold |
| Mar-02-22 | Resumed | BofA Securities | Neutral |
| Oct-06-21 | Upgrade | Needham | Hold → Buy |
| Jul-15-21 | Initiated | UBS | Buy |
| May-25-21 | Initiated | Barclays | Overweight |
| Nov-26-19 | Downgrade | Needham | Buy → Hold |
| Nov-12-19 | Initiated | JP Morgan | Overweight |
| Oct-31-19 | Reiterated | Needham | Buy |
| Oct-04-19 | Reiterated | Needham | Buy |
| Aug-22-19 | Upgrade | Piper Jaffray | Neutral → Overweight |
| Apr-18-19 | Initiated | Stifel | Buy |
| Apr-16-19 | Reiterated | Needham | Buy |
| Jan-23-19 | Reiterated | Needham | Buy |
| Oct-16-18 | Initiated | Barclays | Equal Weight |
| Aug-07-18 | Reiterated | Needham | Buy |
| Aug-02-18 | Reiterated | Needham | Buy |
| Apr-26-18 | Reiterated | Needham | Buy |
| Feb-01-18 | Reiterated | Needham | Buy |
| Jul-27-17 | Reiterated | Needham | Buy |
| Apr-27-17 | Downgrade | Ladenburg Thalmann | Buy → Neutral |
| Apr-27-17 | Reiterated | Needham | Buy |
| Nov-18-16 | Reiterated | Needham | Buy |
| Jul-28-16 | Downgrade | Leerink Partners | Outperform → Mkt Perform |
| Apr-28-16 | Reiterated | Needham | Buy |
| Oct-22-15 | Reiterated | Northland Capital | Market Perform |
View All
Conmed Corp Stock (CNMD) Latest News
Discipline and Rules-Based Execution in CNMD Response - Stock Traders Daily
CONMED Corp stock (US2074101013): Medtech mid-cap in focus after latest earnings and guidance update - AD HOC NEWS
CONMED Corp stock (US2074101013): medtech growth story after latest earnings update - AD HOC NEWS
CONMED to Repurchase $645.2 Million of 2027 Convertible Notes for $637.2 Million Cash - TradingView
CONMED (CNMD) to buy back $645.2M of 2.25% convertible notes due 2027 - Stock Titan
Director at CONMED (NYSE: CNMD) exercises 668 RSUs and receives 5,772-unit equity award - Stock Titan
CONMED (NYSE: CNMD) director gets 5,772 RSUs, converts 668 units - Stock Titan
Director at CONMED (NYSE: CNMD) receives 5,772 RSUs under 2025 incentive plan - Stock Titan
CONMED (NYSE: CNMD) director awarded 5,772 RSUs and exercises 668 into shares - Stock Titan
Director Mark Kaye receives 5,772 RSUs at CONMED (NYSE: CNMD) - Stock Titan
CONMED (NYSE: CNMD) director awarded 5,772 RSUs and converts 668 into common stock - Stock Titan
CONMED (NYSE: CNMD) interim controller details RSU and stock option holdings - Stock Titan
CONMED (CNMD) interim finance chief reports initial stock and option holdings - Stock Titan
Q1 Earnings Outperformers: CONMED (NYSE:CNMD) And The Rest Of The Surgical Equipment & ConsumablesDiversified Stocks - Yahoo Finance
CONMED Board Refresh And Governance Changes Feed Into Valuation Debate - Yahoo Finance
CONMED Corporation Executes First Omnibus Amendment and Increased Facility Activation Notice to Eighth Amended and Restated Credit Agreement - Minichart
Here's Why You Should Retain CONMED Stock in Your Portfolio Now - Yahoo Finance
Conmed secures $450 million term loan facility to repurchase convertible notes - Investing.com
Conmed Secures $450 Million Delayed-Draw Term Loan With JPMorgan to Repurchase 2026 Notes - TradingView
CONMED (NYSE: CNMD) secures $450M term loan to manage 2026 notes - Stock Titan
Why Is Conmed (CNMD) Down 3.1% Since Last Earnings Report? - Yahoo Finance
Clip Applicator Market Will Generate Booming Growth - openPR.com
(CNMD) Movement Within Algorithmic Entry Frameworks - Stock Traders Daily
CONMED Corp stock (US2074101013): focus on growth after latest quarterly results - AD HOC NEWS
CONMED Corporation Announces Results of 2026 Annual Meeting, Amended By-Laws, and Director Compensation Updates - Minichart
Conmed appoints two directors to board effective July 1 - Investing.com
Celine Martin and Jeff Mirviss join ConMed board; Kimberly Lockwood named interim controller - TradingView
New CONMED (NYSE: CNMD) directors, bylaw changes and 2026 vote outcomes - Stock Titan
J&J and Boston Scientific veterans join CONMED's board - Stock Titan
CONMED Corp stock (US2074101013): shares react to Q1 2026 results and updated full-year outlook - AD HOC NEWS
Is the Options Market Predicting a Spike in CONMED Stock? - Yahoo Finance UK
Oppenheimer Asset Management Inc. Has $1.27 Million Stock Holdings in CONMED Corporation $CNMD - MarketBeat
Does CONMED (CNMD) Refocusing Away From Gastroenterology Clarify Its Long-Term Surgical Growth Story? - Yahoo Finance
Assessing CONMED (CNMD) Valuation After A Mixed Stretch In Recent Share Performance - Yahoo Finance
Is CONMED Corporation (CNMD) A Good Stock To Buy Now? - Yahoo Finance
CNMD Q1 Deep Dive: GI Exit Refocuses Growth on Core Surgical Platforms - Yahoo Finance
CONMED (NYSE:CNMD) Stock Rating Lowered by Wall Street Zen - MarketBeat
Healthcare Momentum Story Meets NYSE Composite Trends - Kalkine Media
CONMED (NYSE:CNMD) Price Target Lowered to $39.00 at Wells Fargo & Company - MarketBeat
CNMD SEC FilingsConmed Corp 10-K, 10-Q, 8-K Forms - Stock Titan
Conmed (CNMD) Q1 2026 Earnings Transcript - AOL.com
CONMED (NYSE:CNMD) Price Target Lowered to $40.00 at JPMorgan Chase & Co. - MarketBeat
CONMED Corp 1Q 2026: Revenue $317M, EPS $0.45— 10-Q Summary - TradingView
CONMED (NYSE: CNMD) boosts Q1 2026 profit as margins expand - Stock Titan
CONMED Corporation Q1 2026 Earnings Call Summary - Yahoo Finance
CONMED's Q1 Earnings and Revenues Beat, Organic Sales Outlook Up - Yahoo Finance
Conmed Corp (CNMD) Q1 2026 Earnings Call Highlights: Navigating Challenges and Capitalizing on ... By GuruFocus - Investing.com Canada
CONMED Q1 Earnings Call Highlights - MarketBeat
CONMED (NYSE:CNMD) Releases Earnings Results, Beats Estimates By $0.07 EPS - MarketBeat
CONMED Corporation (NYSE:CNMD) Beats Q1 Estimates and Raises Revenue Guidance, Shares Steady - ChartMill
Compared to Estimates, Conmed (CNMD) Q1 Earnings: A Look at Key Metrics - Yahoo Finance
Conmed Corp Stock (CNMD) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.43%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):